Skip to main content

D. E. Shaw & Co., Inc.

Position in PBYI — Puma Biotechnology, Inc.

CIK 1009207 New York, NY

Position in PBYI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,244,391
-$6,470 QoQ
Shares Held
351,235
-7.2% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Derivatives in PBYI

reported options exposure · as of Dec 31, 2020
CallValue
$0
CallShares
0
PutValue
$290,358
PutShares
28,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,328,350,520 across 180 Biotechnology names. PBYI ranks #111 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PBYI

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,244,391 351,235
2025-12-31 $2,250,861 378,296
2025-09-30 $2,647,555 498,598
2025-06-30 $2,197,875 640,780
2025-03-31 $1,692,128 571,665
2024-12-31 $678,954 222,608
2024-09-30 $146,339 57,388
2022-12-31 $559,138 132,184
2022-09-30 $1,276,349 538,544
2022-06-30 $2,736,204 960,072
2022-03-31 $2,897,230 1,005,983
2021-12-31 $2,237,324 735,962
2021-09-30 $352,406 50,272
2021-06-30 $1,023,625 111,506
2021-03-31 $779,505 80,196
2020-12-31 $357,140 34,809
2020-12-31 $290,358 28,300
2020-09-30 $285,547 28,300
2020-09-30 $304,888 30,217
2020-06-30 $1,981,814 190,011
2020-06-30 $295,169 28,300
2020-03-31 $1,317,424 156,093
2020-03-31 $238,852 28,300